US2006105317A1PendingUtilityA1
Method and solutions for cryopreserving oocytes, especially fresh human oocytes
Est. expiryMar 20, 2020(expired)· nominal 20-yr term from priority
Inventors:Raffaella Fabbri
A01N 1/10A01N 1/125
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In a method for cryopreserving fresh human oocytes, freezing and thawing solutions are used, which solutions include 1,2 propanediol (PROH) and sucrose at a concentration of at least 0.3M. The oocytes are exposed for 13-15 minutes to a solution including 1.5M PROH and 0.3M sucrose before starting the freezing process.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A solution for cryopreserving cells, characterized in that it comprises a permeating cryoprotectant and sucrose at a concentration of at least 0.3M.
13 . The solution of claim 12 , characterized in that the permeating cryoprotectant comprises 1,2-propanediol (PROH) at a concentration of 1.5M and that the solution is adapted for use as a loading solution in cryopreserving processes of oocytes, especially fresh human oocytes.
14 . The solution of claim 12 , characterized in that the permeating cryoprotectant comprises 1,2 propanediol (PROH) at a concentration of 1.0M and that the solution is adapted for use as a thawing solution in cryopreserving processes of oocytes, especially fresh human oocytes.
15 . The solution of claim 12 , characterized in that the permeating cryoprotectant comprises 1,2 propanediol (PROH) at a concentration of 0.5M and that the solution is adapted for use as a thawing solution in cryopreserving processes of oocytes, especially fresh human oocytes.
16 . The solution of claim 12 , characterized in that it is adapted for use as a thawing solution in cryopreserving processes of oocytes, especially fresh human oocytes.Join the waitlist — get patent alerts
Track US2006105317A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.